# EDGAR Filing Document

**Accession Number:** 0001305473
**File Stem:** 0000899140-26-000691
**Filing Date:** 2026-6
**Character Count:** 28802
**Document Hash:** a0f8b99932c59d537102dbf0eaada523
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899140-26-000691.hdr.sgml**: 20260629

**ACCESSION NUMBER**: 0000899140-26-000691

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260625

**FILED AS OF DATE**: 20260629

**DATE AS OF CHANGE**: 20260629

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Holdings Group, LLC
- **CENTRAL INDEX KEY:** 0001305473

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137783

**BUSINESS ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Partners (Delaware) X, L.P.
- **CENTRAL INDEX KEY:** 0001710835

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137778

**BUSINESS ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Partners X (Co-Investors), L.P.
- **CENTRAL INDEX KEY:** 0001710834

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137777

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Associates X, L.P.
- **CENTRAL INDEX KEY:** 0001844845

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137782

**BUSINESS ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** (212) 230-9200

**MAIL ADDRESS:**
- **STREET 1:** 1114 AVENUE OF THE AMERICAS, 36TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Partners (Cayman) X, L.P.
- **CENTRAL INDEX KEY:** 0001710860

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137779

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Partners X, L.P.
- **CENTRAL INDEX KEY:** 0001710959

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137780

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **PROVINCE COUNTRY:** E9
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Insight Venture Associates X, Ltd.
- **CENTRAL INDEX KEY:** 0001803240

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42657
- **FILM NUMBER:** 261137781

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 212-230-9200

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hinge Health, Inc.
- **CENTRAL INDEX KEY:** 0001673743
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 811884841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** 415-689-8429

**MAIL ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

## Exhibit 99.1

**EXHIBIT 99.1**

**<br>EXPLANATION OF RESPONSES**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) Held directly by Insight Venture Partners X, L.P.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2) Held directly by Insight Venture Partners X (Co-Investors), L.P

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(3) Held directly by Insight Venture Partners (Cayman) X, L.P.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(4) Held directly by Insight Venture Partners (Delaware) X, L.P.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(5) Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(6) Insight Holdings Group, LLC ("Holdings") is the sole shareholder of Insight Venture Associates X, Ltd. ("IVA X Ltd"), which is the general partner of Insight Venture Associates X, L.P. ("IVA X"), which is the general partner of each of Insight Venture Partners X, L.P. ("IVP X"), Insight Venture Partners (Cayman) X, L.P. ("IVP Cayman X"), Insight Venture Partners (Delaware) X, L.P. ("IVP Delaware X") and Insight Venture Partners X (Co-Investors), L.P. ("IVP X Co-Investors," collectively with IVP X, IVP Cayman X and IVP Delaware X, the "IVP X Funds") (the IVP X Funds, collectively with Holdings, IVA X Ltd and IVA X, the "Insight Entities"). As a result, the amounts owned by each of the IVP X Funds may be deemed attributable to each of the other Insight Entities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(7) Each of Jeffrey L. Horing, Deven Parekh, Jeffrey Lieberman and Michael Triplett is a member of the board of managers of Holdings and may be deemed to have shared voting and dispositive power over the shares held of record by the IVP X Funds. The foregoing is not an admission by any other Insight Entity that it is the beneficial owner of the shares held of record by the IVP X Funds. Each of the other Insight Entities, Messrs. Horing, Parekh, Lieberman and Triplett disclaims beneficial ownership of the shares held of record by the IVP X Funds, except to the extent of its/his pecuniary interest therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(8) On June 25, 2026, the reporting persons converted each share of Class B Common Stock into one share of Class A Common Stock. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.535 to $81.530, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (9)-(13).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.535 to $82.530, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (9)-(13).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.550 to $83.545, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (9)-(13).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.550 to $84.545, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (9)-(13).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(13) The price reported in Column 4 is $84.59. These shares were sold in multiple transactions. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (9)-(13).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(14) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted on August 20, 2025.

## Exhibit 99.2

**EXHIBIT 99.2**

**JOINT FILERS' SIGNATURES**

---

| | |
|:---|:---|
| &nbsp;&nbsp; INSIGHT HOLDINGS GROUP, LLC<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Attorney-in-Fact | &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; INSIGHT VENTURE ASSOCIATES X, LTD.<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer<br>| &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; INSIGHT VENTURE ASSOCIATES X, L.P.<br> By: Insight Venture Associates X, Ltd., its general partner<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer | &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; <br> INSIGHT VENTURE PARTNERS X, L.P. <br> By: Insight Venture Associates X, L.P., its general partner<br> By: Insight Venture Associates X, Ltd., its general partner<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer | &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; INSIGHT VENTURE PARTNERS (CAYMAN) X, L.P.<br> By: Insight Venture Associates X, L.P., its general partner<br> By: Insight Venture Associates X, Ltd., its general partner<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer | &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; INSIGHT VENTURE PARTNERS (DELAWARE) X, L.P. <br> By: Insight Venture Associates X, L.P., its general partner<br> By: Insight Venture Associates X, Ltd., its general partner<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer | &nbsp;&nbsp; Date: _______<u>06/29/2026</u>____ |
| &nbsp;&nbsp; <br>INSIGHT VENTURE PARTNERS X (CO-INVESTORS), L.P. <br> By: Insight Venture Associates X, L.P., its general partner<br> By: Insight Venture Associates X, Ltd., its general partner<br> By: <u>_____/s/Andrew Prodromos_______________</u><br> Name: Andrew Prodromos<br> Title: Authorized Officer | &nbsp;&nbsp; <br>Date: _______<u>06/29/2026</u>____ |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Holdings Group, LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Associates X, L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Associates X, Ltd.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Partners X, L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Partners (Cayman) X, L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Partners (Delaware) X, L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Insight Venture Partners X (Co-Investors), L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O INSIGHT PARTNERS<br>1114 AVENUE OF THE AMERICAS, 36TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10036<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hinge Health, Inc. [ HNGE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2026-06-29 |  | C |  | 732444 | A | <sup>(8)</sup> | 732444 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | C |  | 17427 | A | <sup>(8)</sup> | 17427 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | C |  | 600613 | A | <sup>(8)</sup> | 600613 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | C |  | 116183 | A | <sup>(8)</sup> | 116183 | I | See footnotes<sup>(4)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 216787 | D | 81.3050<sup>(9)</sup> | 515657 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 5158 | D | 81.3050<sup>(9)</sup> | 12269 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 177768 | D | 81.3050<sup>(9)</sup> | 422845 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 34387 | D | 81.3050<sup>(9)</sup> | 81796 | I | See footnotes<sup>(4)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 72672 | D | 82.0479<sup>(10)</sup> | 442985 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 1729 | D | 82.0479<sup>(10)</sup> | 10540 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 59592 | D | 82.0479<sup>(10)</sup> | 363253 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 11528 | D | 82.0479<sup>(10)</sup> | 70268 | I | See footnotes<sup>(4)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 162965 | D | 83.1765<sup>(11)</sup> | 280020 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 3877 | D | 83.1765<sup>(11)</sup> | 6663 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 133633 | D | 83.1765<sup>(11)</sup> | 229620 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 25850 | D | 83.1765<sup>(11)</sup> | 44418 | I | See footnotes<sup>(4)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 279671 | D | 84.0207<sup>(12)</sup> | 349 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 6654 | D | 84.0207<sup>(12)</sup> | 9 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 229334 | D | 84.0207<sup>(12)</sup> | 286 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 44363 | D | 84.0207<sup>(12)</sup> | 55 | I | See footnotes<sup>(4)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 349 | D | 84.5900<sup>(13)</sup> | 0 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 9 | D | 84.5900<sup>(13)</sup> | 0 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 286 | D | 84.5900<sup>(13)</sup> | 0 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class A Common Stock | 2026-06-29 |  | S<sup>(14)</sup> |  | 55 | D | 84.5900<sup>(13)</sup> | 0 | I | See footnotes<sup>(4)(6)(7)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Class B Common Stock | <sup>(8)</sup> | 2026-06-25 |  | C |  |  | 732444 | <sup>(8)</sup> | <sup>(8)</sup> | Class A Common Stock | 732444 | <sup>(5)</sup> | 3217008 | I | See footnotes<sup>(1)(6)(7)</sup> |
| Class B Common Stock | <sup>(8)</sup> | 2026-06-25 |  | C |  |  | 17427 | <sup>(8)</sup> | <sup>(8)</sup> | Class A Common Stock | 17427 | <sup>(5)</sup> | 76545 | I | See footnotes<sup>(2)(6)(7)</sup> |
| Class B Common Stock | <sup>(8)</sup> | 2026-06-25 |  | C |  |  | 600613 | <sup>(8)</sup> | <sup>(8)</sup> | Class A Common Stock | 600613 | <sup>(5)</sup> | 2637985 | I | See footnotes<sup>(3)(6)(7)</sup> |
| Class B Common Stock | <sup>(8)</sup> | 2026-06-25 |  | C |  |  | 116183 | <sup>(8)</sup> | <sup>(8)</sup> | Class A Common Stock | 116183 | <sup>(5)</sup> | 510292 | I | See footnotes<sup>(4)(6)(7)</sup> |

---

### Footnotes:

(1) See Exhibit 99.1

(2) See Exhibit 99.1

(3) See Exhibit 99.1

(4) See Exhibit 99.1

(5) See Exhibit 99.1

(6) See Exhibit 99.1

(7) See Exhibit 99.1

(8) See Exhibit 99.1

(9) See Exhibit 99.1

(10) See Exhibit 99.1

(11) See Exhibit 99.1

(12) See Exhibit 99.1

(13) See Exhibit 99.1

(14) See Exhibit 99.1

**Remarks:**
This Form 4 is the second of two Form 4s filed relating to the same event. The Form 4 has been split into two filings because there are more than 30 rows in Table I, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 rows in Table I. Each Form 4 is filed by Designated Filer, Insight Holdings Group, LLC.

**Signature:** Insight Venture Partners X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

**Signature:** Insight Venture Partners (Cayman) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

**Signature:** Insight Venture Partners (Delaware) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

**Signature:** Insight Venture Partners X (Co-Investors), L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

**Signature:** Insight Holdings Group, LLC, By: /s/ Andrew Prodromos/Attorney-in-Fact  
**Date:** 2026-06-29

**Signature:** Insight Venture Associates X Ltd., By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

**Signature:** Insight Venture Associates X, L.P., By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer  
**Date:** 2026-06-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**